Bullinger L - Search Results

1

Concomitant Cytotoxic Effector Differentiation of CD4⁺ and CD8⁺ T Cells in Response to EBV-Infected B Cells.

Tamura Y, Yamane K, Kawano Y, Bullinger L, Wirtz T, Weber T, Sander S, Ohki S, Kitajima Y, Okada S, Rajewsky K, Yasuda T. Tamura Y, et al. Among authors: bullinger l. Cancers (Basel). 2022 Aug 25;14(17):4118. doi: 10.3390/cancers14174118. Cancers (Basel). 2022. PMID: 36077655 Free PMC article.

2

Repressing the repressor: a new mode of MYC action in lymphomagenesis.

Sander S, Bullinger L, Wirth T. Sander S, et al. Among authors: bullinger l. Cell Cycle. 2009 Feb 15;8(4):556-9. doi: 10.4161/cc.8.4.7599. Epub 2009 Feb 10. Cell Cycle. 2009. PMID: 19197161

3

Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias.

Koenigsmann J, Rudolph C, Sander S, Kershaw O, Gruber AD, Bullinger L, Schlegelberger B, Carstanjen D. Koenigsmann J, et al. Among authors: bullinger l. Blood. 2009 May 7;113(19):4690-701. doi: 10.1182/blood-2008-05-158485. Epub 2009 Feb 19. Blood. 2009. PMID: 19228926 Free article.

4

Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.

Sander S, Calado DP, Srinivasan L, Köchert K, Zhang B, Rosolowski M, Rodig SJ, Holzmann K, Stilgenbauer S, Siebert R, Bullinger L, Rajewsky K. Sander S, et al. Among authors: bullinger l. Cancer Cell. 2012 Aug 14;22(2):167-79. doi: 10.1016/j.ccr.2012.06.012. Cancer Cell. 2012. PMID: 22897848 Free PMC article.

5

PI3 Kinase and FOXO1 Transcription Factor Activity Differentially Control B Cells in the Germinal Center Light and Dark Zones.

Sander S, Chu VT, Yasuda T, Franklin A, Graf R, Calado DP, Li S, Imami K, Selbach M, Di Virgilio M, Bullinger L, Rajewsky K. Sander S, et al. Among authors: bullinger l. Immunity. 2015 Dec 15;43(6):1075-86. doi: 10.1016/j.immuni.2015.10.021. Epub 2015 Nov 24. Immunity. 2015. PMID: 26620760 Free article.

6

Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells.

Kabrani E, Chu VT, Tasouri E, Sommermann T, Baßler K, Ulas T, Zenz T, Bullinger L, Schultze JL, Rajewsky K, Sander S. Kabrani E, et al. Among authors: bullinger l. Blood. 2018 Dec 20;132(25):2670-2683. doi: 10.1182/blood-2018-06-856203. Epub 2018 Oct 17. Blood. 2018. PMID: 30333121 Free article.

7

Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New Agents.

Halik A, Arends CM, Bullinger L, Damm F, Frick M. Halik A, et al. Among authors: bullinger l. Cancers (Basel). 2022 Mar 26;14(7):1689. doi: 10.3390/cancers14071689. Cancers (Basel). 2022. PMID: 35406464 Free PMC article. Review.

8

Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia.

Lang TJL, Damm F, Bullinger L, Frick M. Lang TJL, et al. Among authors: bullinger l. Cancers (Basel). 2023 Sep 15;15(18):4573. doi: 10.3390/cancers15184573. Cancers (Basel). 2023. PMID: 37760544 Free PMC article. Review.

9

Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.

Rücker FG, Sander S, Döhner K, Döhner H, Pollack JR, Bullinger L. Rücker FG, et al. Among authors: bullinger l. Leukemia. 2006 Jun;20(6):994-1001. doi: 10.1038/sj.leu.2404235. Leukemia. 2006. PMID: 16721385

10

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, Möller P, Stilgenbauer S, Pollack JR, Wirth T. Sander S, et al. Among authors: bullinger l. Blood. 2008 Nov 15;112(10):4202-12. doi: 10.1182/blood-2008-03-147645. Epub 2008 Aug 19. Blood. 2008. PMID: 18713946 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters